Aaron Zhou

[email protected]

Mr Zhou’s practice focuses on cross-border and domestic mergers and acquisitions, private equity investment, venture capital investment, foreign direct investment, joint ventures and technology/IP licensing. Mr Zhou’s extensive experiences in the pharmaceutical and healthcare field include out-licence/in-licence and supply agreements for the development and commercialisation of new drugs and generic drugs, sale and purchase of pharmaceutical-related assets and businesses, investments in and acquisitions of pharmaceutical and healthcare companies, research collaboration and manufacturing services agreements, and FCPA-related and compliance matters. Mr Zhou has over 16 years’ legal experience, including five years at Davis Polk and three years as the Asia Pacific legal head of a Fortune Global 50 company. Mr Zhou is a member of the PRC Bar and of the New York State Bar.

Content from this contributor


The Law Reviews content